CN Stock MarketDetailed Quotes

600285 Henan Lingrui Pharmaceutical

Watchlist
  • 25.67
  • +0.58+2.31%
Not Open Oct 21 15:00 CST
14.56BMarket Cap21.92P/E (TTM)

Henan Lingrui Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Henan Lingrui Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.239B--
--2024/FY-- / 3.754B--
--2023/FY3.311B / 3.455B--
--2022/FY3.002B / 3.146B--
--2021/FY2.694B / 2.780B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.239B--
--2024/FY-- / 3.754B--
--2023/FY3.311B / 3.455B--
--2022/FY3.002B / 3.146B--
--2021/FY2.694B / 2.780B--

Unlock Free Earnings Estimates

Henan Lingrui Pharmaceutical Earnings Reports

  • Henan Lingrui Pharmaceutical Semi-Annual Report 2024

    Aug 12 12:00 ET

  • Summary of Henan Lingrui Pharmaceutical's Half-Year Report in 2024.

    Aug 12 12:00 ET

  • Ling Rui Pharmaceutical's 2024 First Quarter Report

    Apr 25 12:00 ET

  • Summary of Ling Rui Pharmaceutical's 2023 Annual Report

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 21, 2024

    Strong Buy

    • Strong Buy

      82.35%

    • Buy

      17.65%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data